Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-risk breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-risk breast cancer

Published:2000-09 Issue:2 Volume:48 Page:393-397
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Bellon Jennifer R,Lindsley Karen L,Ellis Georgiana K,Gralow Julie R,Livingston Robert B,Austin Seymour Mary M

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference36 articles.

1. Emerging role of docetaxel (Taxotere) in advanced non–small cell lung cancer;Gandara;Semin Oncol,1999

2. Taxanes as radiosensitizers for head and neck cancer;Herscher;Curr Opin Oncol,1999

3. The emerging role of paclitaxel in breast cancer therapy;Seidman;Clin Cancer Res,1995

4. Docetaxel in head and neck cancer;Colevas;Am J Clin Oncol,1998

5. An expanding role for docetaxel;Hortobagyi;Semin Oncol,1998

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Scleroderma-like Lesions in a Patient Undergoing Combined Pembrolizumab and Routine Chemotherapy: A Case Report and Literature Review;Medicina;2024-07-03

2. Ultrasound Histogram Assessment of Acute Breast Toxicity After Breast Cancer Radiation Therapy: A Prospective Longitudinal Study;Ultrasound in Medicine & Biology;2023-01

3. Fabrication and evaluation of Docetaxel doped ZnO nanoparticles incorporated PCL nanofibers for its hemocompatibility, cytotoxicity and apoptotic effects against A549;Materialia;2022-03

4. Concomitant Radiation and Systemic Therapy in the Adjuvant and Metastatic Setting;Breast Cancer Radiation Therapy;2022

5. Concurrent Chemo-radiation As a Means of Achieving Pathologic Complete Response in Triple Negative Breast Cancer;Clinical Breast Cancer;2021-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3